COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”

Multiple Sclerosis therapies and COVID-19 What the bleep do we know? @ResearchGate #COVID19 community page. Read it here https://t.co/2K4LlN23MY

@MedscapeNeuro https://t.co/2K4LlN23MY

@neuropsychblog https://t.co/2K4LlN23MY

@MedscapeNeuro https://t.co/2K4LlN23MY

@NeurologyCP https://t.co/2K4LlN23MY

@theylovedaija_ https://t.co/2K4LlN23MY

@TheDianeKramer @mssociety https://t.co/2K4LlN23MY

@GreenJournal https://t.co/2K4LlN23MY

@MSIRELAND @HSELive @naiireland @MSTrust @leinsterrugby @Sabina_Brennan @susancoote @MSIntFederation @eumsplatform @DisabilityFed https://t.co/2K4LlN23MY

@FrontGenetics https://t.co/2K4LlN23MY

@ScienceNews https://t.co/2K4LlN23MY

@mendibe_mar https://t.co/2K4LlN23MY

New article: COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: "what the bleep do we know?" https://t.co/VyFSE0vPeR #MS #multiplesclerosis #neurology

RT @salmanmansoordr: COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: "what the b…

COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: "what the bleep do we know?" https://t.co/2K4LlN23MY #irishneurologY #neurologyCOVID #Coronavirus #cuh #ireland #AAN #Neurology #NeurologyToday #Mult